Upgrade to SI Premium - Free Trial

Anika Therapeutics (ANIK)

15.01 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/26)

Latest Headlines

Form SCHEDULE 13G/A Anika Therapeutics, Inc. Filed by: BlackRock Portfolio Management LLC July 17, 2026 11:33 AM - SEC Filing Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 July 15, 2026 4:01 PM - StreetInsider Form 8-K Anika Therapeutics, Inc. For: Jul 10 July 14, 2026 5:00 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Fischetti Gary P June 23, 2026 4:30 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Richard Stephen June 23, 2026 4:30 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Capper Joseph H June 23, 2026 4:30 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: HENNEMAN JOHN B III June 23, 2026 4:30 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: CONLEY SHERYL L June 23, 2026 4:30 PM - SEC Filing Form 8-K Anika Therapeutics, Inc. For: Jun 18 June 23, 2026 4:06 PM - SEC Filing Form DEFA14A Anika Therapeutics, Inc. June 8, 2026 9:26 AM - SEC Filing Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 5, 2026 5:00 PM - StreetInsider Form 4 Anika Therapeutics, Inc. For: Jun 03 Filed by: Griffin Stephen D. June 5, 2026 4:05 PM - SEC Filing Form DEFA14A Anika Therapeutics, Inc. June 1, 2026 11:13 AM - SEC Filing Form 4 Anika Therapeutics, Inc. For: May 01 Filed by: HENNEMAN JOHN B III May 4, 2026 8:34 AM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Apr 30 Filed by: Griffin Stephen D. April 30, 2026 5:23 PM - SEC Filing TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter April 30, 2026 4:43 PM - Globe NewsWire Form 10-Q Anika Therapeutics, Inc. For: Mar 31 April 30, 2026 6:10 AM - SEC Filing Form SCHEDULE 13G Anika Therapeutics, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 4:37 PM - SEC Filing Form 8-K Anika Therapeutics, Inc. For: Apr 24 April 29, 2026 7:20 AM - SEC Filing Anika Therapeutics (ANIK) Tops Q1 EPS by 45c ; Offers Guidance April 29, 2026 7:12 AM - StreetInsider Anika Reports First Quarter 2026 Financial Results April 29, 2026 7:05 AM - Globe NewsWire Form ARS Anika Therapeutics, Inc. For: Dec 31 April 28, 2026 4:53 PM - SEC Filing Form DEFA14A Anika Therapeutics, Inc. April 28, 2026 4:51 PM - SEC Filing Form DEF 14A Anika Therapeutics, Inc. For: Jun 18 April 28, 2026 4:48 PM - SEC Filing Full Article List